Outcome of Relapse in Children/Adolescents with B-Cell Non-Hodgkin Lymphoma (B-NHL) and Mature Acute Leukemia (B-AL) Treated in the Rituximab (R) Era

被引：0
|
作者：
Rigaud, C. [1 ]
Auperin, A. [2 ]
Jourdain, A. [3 ]
Schmitt, C. [4 ]
Paillard, C. [5 ]
Couec, M. L. [6 ]
Aladjidi, N. [7 ]
Gandemer, V. [8 ]
Lambilliote, A. [9 ]
Plat, G. [10 ]
Michon, J. [11 ]
Leblanc, T. [12 ]
Patte, C. [1 ]
Minard-Colin, V. [1 ]
机构：
[1] Inst Gustave Roussy, Paediat Oncol, Villejuif, France
[2] Inst Gustave Roussy, Biostat, Villejuif, France
[3] Ctr Hosp Univ Tours, Paediat Oncol, Tours, France
[4] Ctr Hosp Univ Nancy, Paediat Oncol, Nancy, France
[5] Ctr Hosp Univ Strasbourg, Paediat Oncol, Strasbourg, France
[6] Ctr Hosp Univ Nantes, Paediat Haematol, Nantes, France
[7] Ctr Hosp Univ Bordeaux, Paediat Oncol, Bordeaux, France
[8] Ctr Hop Univ Rennes, Paediat Oncol, Rennes, France
[9] Ctr Hosp Univ Lille, Paediat Oncol, Lille, France
[10] Ctr Hosp Univ Toulouse, Paediat Oncol, Toulouse, France
[11] Inst Curie, Pedaitr Oncol, Paris, France
[12] Hop Robert Debre, AP HP, Paediat Haematol, Paris, France
来源：
PEDIATRIC BLOOD & CANCER | 2016年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-124
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [21] Outcome of relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in the Rituximab Era: a study of the Societe Francaise des Cancers de l'Enfant
    Minard-Colin, Veronique
    Auperin, Anne
    Jourdain, Anne
    Schmitt, Claudine
    Thomas, Caroline
    Aladjidi, Nathalie
    Gandemer, Virginie
    Lambliotte, Anne
    Plat, Genevieve
    Michon, Jean
    Leblanc, Thierry
    Patte, Catherine
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 6 - 6
  • [22] Biallelic inactivation of TP53 is associated with an increased risk of relapse in paediatric B-cell Non-Hodgkin lymphoma (B-NHL)
    Newman, Alexander M.
    Zaka, Masood
    Zhou, Peixun
    Erhorn, Amy
    Barnard, Amy
    Crossland, Rachel E.
    Wilkinson, Sarah
    Enshaei, Amir
    Taj, Mary
    Wood, Katrina
    Televantou, Despina
    Turner, Suzanne D.
    Burke, Amos
    Harrison, Christine J.
    Bomken, Simon
    Bacon, Chris M.
    Rand, Vikki
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 60 - 60
  • [23] Biallelic Inactivation of TP53 is Associated with an Increased Risk of Relapse in Paediatric B-Cell Non-Hodgkin Lymphoma (B-NHL)
    Newman, A. M.
    Zaka, M.
    Zhou, P.
    Erhorn, A.
    Barnard, A.
    Crossland, R. E.
    Wilkinson, S.
    Wood, K.
    Televantou, D.
    Harrison, C. J.
    Bomken, S.
    Bacon, C. M.
    Rand, V.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S46 - S47
  • [24] Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy
    Gerrard, Mary
    Waxman, Ian M.
    Sposto, Richard
    Auperin, Anne
    Perkins, Sherrie L.
    Goldman, Stanton
    Harrison, Lauren
    Pinkerton, Ross
    McCarthy, Keith
    Raphael, Martine
    Patte, Catherine
    Cairo, Mitchell S.
    BLOOD, 2013, 121 (02) : 278 - 285
  • [25] Treatment of acute lymphoblastic mature B-cell leukemia (B-NHL/ALL) in children and adolescents by intensive polychemotherapy and rituximab (NHL-2004m protocol): Pilot results
    Samochatova, E. V.
    Shelikhova, L. N.
    Myakova, N. V.
    Fechina, L. G.
    Belogurova, M. B.
    Inyushkina, E. V.
    Litvinov, D. V.
    Shamardina, A. V.
    Basharova, E. V.
    Ryskal, O. V.
    Abdullaev, R.
    Baidun, L. V.
    Plyasunova, S. A.
    Konovalov, D. M.
    Maschan, A. A.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2007, 52 (06): : 9 - 16
  • [26] Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children
    Minard-Colin, Veronique
    Auperin, Anne
    Pillon, Marta
    Burke, G. A. Amos
    Barkauskas, Donald A.
    Wheatley, Keith
    Delgado, Rafael F.
    Alexander, Sarah
    Uyttebroeck, Anne
    Bollard, Catherine M.
    Zsiros, Jozsef
    Csoka, Monika
    Kazanowska, Bernarda
    Chiang, Alan K.
    Miles, Rodney R.
    Wotherspoon, Andrew
    Adamson, Peter C.
    Vassal, Gilles
    Patte, Catherine
    Gross, Thomas G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (23): : 2207 - 2219
  • [27] Integrated population modeling of loncastuximab tesirine (Lonca) exposure in B-cell non-Hodgkin lymphoma (B-NHL).
    Solh, Melhem
    Alderuccio, Juan Pablo
    Stathis, Anastasios
    Ungar, David
    Liao, Sam
    Khouri, Lisa
    Zhang, Xiaoyan
    Boni, Joseph
    CANCER RESEARCH, 2021, 81 (13)
  • [28] Overt B-cell non-Hodgkin's lymphoma (B-NHL): Role of hepatitis C virus (HCV).
    Germanidis, G
    Haioun, C
    Gaulard, P
    Reyes, F
    Dhumeaux, D
    Pawlotsky, JM
    HEPATOLOGY, 1999, 30 (04) : 605A - 605A
  • [29] Overt B-cell non-Hodgkin's lymphoma (B-NHL):: Role of hepatitis C virus (HCV)
    Germanidis, G
    Haioun, C
    Gaulard, P
    Castéra, L
    Reyes, F
    Dhumeaux, D
    Pawlotsky, JM
    JOURNAL OF HEPATOLOGY, 2000, 32 : 99 - 99
  • [30] A study of rituximab and ifosfamide, carboplatin, etoposide (ICE) chemotherapy in children with recurrent/refractory B-cell non-Hodgkin lymphoma (NHL) and mature B-cell acute lymphoblastic leukemia (B-ALL). A children's oncology group report
    Griffin, T.
    Weitzman, S.
    Weinstein, H.
    Chang, M.
    Hutchison, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 109 - 109
12345